Related Experiment Video
Updated: Jul 8, 2026
Cell Population Analyses During Skin Carcinogenesis
Published on: August 21, 2013
Tuberin-heterozygous cell line TSC2ang1 as a model for tuberous sclerosis-associated skin lesions
Pawel K Wlodarski1, Radoslaw Maksym, Monika Oldak
1Department of Histology and Embryology, Center for Biostructure Research, Medical University of Warsaw, Poland.
Abstract:
Tuberous sclerosis (TS), neurological disorder manifesting with the formation of tumors in numerous organ systems, is a disease associated with the upregulation of mammalian target of rapamycin (mTOR) pathway. It has been found that in healthy individuals two tumor suppressor genes, TSC1 and TSC2, encoding proteins called hamartin and tuberin, respectively, are responsible for the control over mTOR kinase. Loss of one of these genes constitutes the genetic background of TS. In the current study, we aimed at evaluating the fitness of the only TS-associated sarcoma cell line deposited in American Tissue Culture Collection, TSC2ang1, for the in vitro studies on TS. We found that the line shows a stable chromosome pattern with typical Robertsonian translocations. Similarly to primary tumors from TS patients, TSC2ang1 cells respond to rapamycin-induced mTOR inhibition. The cells demonstrate activation of both Akt and Erk pathways, but inhibition of neither of them is as effective as mTOR suppression when considering proliferation potential. Based on these results we propose TSC2ang1 as a good and stable model for pathophysiological and pharmacological studies on skin lesions in TS.
Insights
Tuberous sclerosis (TS) is a disorder linked to the mTOR pathway. The TSC2ang1 cell line is a stable, reliable model for studying TS, particularly its skin lesions, and testing potential treatments.
Area of Science:
- Oncology
- Genetics
- Cell Biology
Background:
- Tuberous sclerosis (TS) is a genetic disorder characterized by tumor formation across organ systems.
- The mammalian target of rapamycin (mTOR) pathway is frequently upregulated in TS.
- Tumor suppressor genes TSC1 and TSC2 normally regulate the mTOR pathway.
Purpose of the Study:
- To evaluate the TSC2ang1 sarcoma cell line as a model for in vitro studies of Tuberous Sclerosis.
- To assess the suitability of TSC2ang1 for investigating TS pathophysiology and treatment.
Main Methods:
- Cytogenetic analysis of the TSC2ang1 cell line.
- Assessment of TSC2ang1 cell response to rapamycin (mTOR inhibitor).
- Evaluation of Akt and Erk pathway activation and inhibition effects on proliferation.
Main Results:
- The TSC2ang1 cell line exhibits a stable chromosomal pattern with Robertsonian translocations.
- TSC2ang1 cells respond to rapamycin, confirming mTOR pathway inhibition.
- While Akt and Erk pathways are activated, mTOR inhibition is most effective in reducing proliferation.
Conclusions:
- The TSC2ang1 cell line is a robust and stable model for in vitro research on Tuberous Sclerosis.
- This cell line is suitable for pathophysiological and pharmacological studies, especially concerning TS skin lesions.
